GRTX

Galera Therapeutics, Inc.

Latest Form 4:Sale$1KbySorensen Mel (President and CEO) · filed Nov 24, 2025

Galera Therapeutics, Inc. (GRTX) has 8 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 5, 2026.

  • Industry:Biotechnology
  • CEO:J. Mel Sorensen
  • Employees:3
  • HQ:Malvern, PA, US
  • IPO:2019-11-07

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Source
Sorensen MelFirst filing
Sale$1KNov 24SEC ↗

Related companies

Galera Therapeutics, Inc. is in the Healthcare sector.